Login
Business
Entertainment
World
Health
Environment
Lifestyle
National
Science
Sports
World
Movies
Web Series
Technology
Cricket
Coronavirus
Auto
Ajab Ghazab
Finance
India
International
Religious
Politics
Home Articles Neck Center of Excellence
Researchers find ways immunotherapy affects COVID-19 outcomes \
3 min read
\
\

Researchers find ways immunotherapy affects COVID-19 outcomes

 06-Nov-2022
Researchers discovered a connection between COVID-19 severity and immunotherapy for cancer patient and shared more information.
06-Nov-2022 Health
\
Study investigates how immunotherapy affects COVID-19 outcomes \
3 min read
\
\

Study investigates how immunotherapy affects COVID-19 outcomes

 03-Nov-2022
A new study led by a University of Cincinnati researcher provides more clarity on how immunotherapy treatment for patients with cancer affects COVID-19 severity.
03-Nov-2022 Health
\
Study investigates how immunotherapy affects COVID-19 outcomes \
3 min read
\
\

Study investigates how immunotherapy affects COVID-19 outcomes

 03-Nov-2022
A new study led by a University of Cincinnati researcher provides more clarity on how immunotherapy treatment for patients with cancer affects COVID-19 severity.
03-Nov-2022 Health
\
Study: Head, neck cancer treatment can be improved by immunotherapy drug \
10 min read
\
\

Study: Head, neck cancer treatment can be improved by immunotherapy drug

 06-Mar-2022
Ohio [US], March 5 (ANI): By adding an immunotherapy drug to the standard of care treatment regimens, the survival rates for head and neck cancer patients with intermediate-risk features increased, suggests a recently conducted clinical trial by the University of Cincinnati.
06-Mar-2022 Science
\
Immunotherapy drug strengthens head, neck cancer treatment: Study \
10 min read
\
\

Immunotherapy drug strengthens head, neck cancer treatment: Study

 01-Mar-2022
Ohio [US], March 1 (ANI): A recently conducted clinical trial by the University of Cincinnati showed that by adding an immunotherapy drug to the standard of care treatment regimens, the survival rates for head and neck cancer patients with intermediate-risk features has increased.
01-Mar-2022 Health
\